Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes.

Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE.

Exp Clin Psychopharmacol. 2002 Aug;10(3):228-40.

PMID:
12233983
2.

A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes.

Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE.

Exp Clin Psychopharmacol. 2001 Feb;9(1):14-23.

PMID:
11519628
3.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
4.

Effects of reinforcer magnitude on data-entry productivity in chronically unemployed drug abusers participating in a Therapeutic Workplace.

Wong CJ, Sheppard JM, Dallery J, Bedient G, Robles E, Svikis D, Silverman K.

Exp Clin Psychopharmacol. 2003 Feb;11(1):46-55.

PMID:
12622343
5.

A randomized controlled trial of the therapeutic workplace for community methadone patients: a partial failure to engage.

Knealing TW, Wong CJ, Diemer KN, Hampton J, Silverman K.

Exp Clin Psychopharmacol. 2006 Aug;14(3):350-60.

PMID:
16893278
6.

Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.

Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML.

Exp Clin Psychopharmacol. 2001 Aug;9(3):317-25.

PMID:
11534542
7.

The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos JM, Silverman K.

Prev Med. 2014 Nov;68:62-70. doi: 10.1016/j.ypmed.2014.02.021. Epub 2014 Mar 4.

8.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
9.

A web-based therapeutic workplace for the treatment of drug addiction and chronic unemployment.

Silverman K, Wong CJ, Grabinski MJ, Hampton J, Sylvest CE, Dillon EM, Wentland RD.

Behav Modif. 2005 Mar;29(2):417-63.

PMID:
15657415
10.

Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.

Dunn KE, Defulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.

Exp Clin Psychopharmacol. 2013 Feb;21(1):74-83. doi: 10.1037/a0030743. Epub 2012 Dec 3.

11.

A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.

Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML.

J Consult Clin Psychol. 2004 Oct;72(5):839-54.

PMID:
15482042
12.

Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.

Katz EC, Chutuape MA, Jones HE, Stitzer ML.

Exp Clin Psychopharmacol. 2002 May;10(2):136-43.

PMID:
12022799
13.

Contingency management of reliable attendance of chronically unemployed substance abusers in a therapeutic workplace.

Wong CJ, Dillon EM, Sylvest CE, Silverman K.

Exp Clin Psychopharmacol. 2004 Feb;12(1):39-46.

PMID:
14769098
14.

Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients.

Dunn KE, Fingerhood M, Wong CJ, Svikis DS, Nuzzo P, Silverman K.

Exp Clin Psychopharmacol. 2014 Feb;22(1):75-85. doi: 10.1037/a0034863.

15.

Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance.

Downey KK, Helmus TC, Schuster CR.

Exp Clin Psychopharmacol. 2000 May;8(2):176-84.

PMID:
10843300
16.

Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation.

Gruber K, Chutuape MA, Stitzer ML.

Drug Alcohol Depend. 2000 Jan 1;57(3):211-23.

PMID:
10661672
17.

Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial.

DeFulio A, Donlin WD, Wong CJ, Silverman K.

Addiction. 2009 Sep;104(9):1530-8. doi: 10.1111/j.1360-0443.2009.02657.x.

18.

Coerced treatment for substance abuse problems detected through workplace urine surveillance: is it effective?

Lawental E, McLellan AT, Grissom GR, Brill P, O'Brien C.

J Subst Abuse. 1996;8(1):115-28.

PMID:
8743772
19.

A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention.

Aklin WM, Wong CJ, Hampton J, Svikis DS, Stitzer ML, Bigelow GE, Silverman K.

J Subst Abuse Treat. 2014 Nov-Dec;47(5):329-38. doi: 10.1016/j.jsat.2014.06.013. Epub 2014 Jul 12.

20.

Behavioral contingencies improve counseling attendance in an adaptive treatment model.

Brooner RK, Kidorf MS, King VL, Stoller KB, Peirce JM, Bigelow GE, Kolodner K.

J Subst Abuse Treat. 2004 Oct;27(3):223-32.

PMID:
15501375

Supplemental Content

Support Center